SB

Srilatha Bollareddy

Active Director Director DIN 09561290
DIN 09561290 First appointment Apr 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Srilatha Bollareddy

Data last updated:

Srilatha Bollareddy is a Director at Asrima Pharma Private Limited (since 2022). The company operates in Chemicals.

DIN 09561290
Primary Designation Director
Industry Chemicals
First Appointment 05 Apr 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Asrima Pharma Private Limited U24230TG2022PTC161270
Director05 Apr 20222022Active

Board colleagues of Srilatha Bollareddy

NameDINCompanyDesignation
Ashok Reddy Ballareddy05273801Asrima Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Asrima Pharma Private Limited
Premium access

Shareholding and investment profile for Srilatha Bollareddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srilatha Bollareddy

Srilatha Bollareddy currently holds 1 directorship: Asrima Pharma Private Limited (Director, since 05 Apr 2022).

Srilatha Bollareddy was first appointed on 05 Apr 2022 as Director at Asrima Pharma Private Limited.

The current boards of Srilatha Bollareddy's companies include Ashok Reddy Ballareddy (Asrima Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available